<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON
NASDAQ INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
AND RULE 13A-17 OR 15D-17 THEREUNDER
OXIS INTERNATIONAL, INC.
- --------------------------------------------------------------------------------
(EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER)
6040 N. CUTTER CIRCLE, SUITE 317, PORTLAND, OR. 97217-3935
- --------------------------------------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
Issuer's telephone number, including area code (503) 283-3911
--------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding:
1. Title of security Common Stock
---------------------------------------------------------
2. Number of shares outstanding before the change 10,683,687
---------------------------
3. Number of shares outstanding after the change 12,124,423
---------------------------
4. Effective date of change July 19, 1995
-------------------------------------------------
5. Method of change: Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of stock for
treasury, etc.)
Merger
- ------------------------------------------------------------------------------
Give brief description of transaction: On July 19, 1995, Therox
------------------------
Pharmaceuticals, Inc. ("Therox") was merged with and into OXIS Acquisition
- --------------------------------------------------------------------------
Corporation ("OXISub"), a wholly-owned subsidiary of Issuer with OXISub as the
- ------------------------------------------------------------------------------
surviving corporation. An aggregate of 1,440,736 shares of Issuer's Common
- ---------------------------------------------------------------------------
Stock was issued in exchange for all of the outstanding shares of Therox stock.
- -------------------------------------------------------------------------------
Date: July 26, 1995 /s/ Ray R. Rogers
----------------------------
Ray R. Rogers
Chairman of the Board,
OXIS International, Inc.
